Results 211 to 220 of about 43,529 (272)
Some of the next articles are maybe not open access.
Current Osteoporosis Reports, 2008
The finding of low bone mineral density with a T-score of -2.5 or below on dual energy x-ray absorptiometry is usually reported as indicating that the patient has "osteoporosis" according to the World Health Organization classification, and, in postmenopausal women, it is often assumed that this is due to estrogen deficiency.
+5 more sources
The finding of low bone mineral density with a T-score of -2.5 or below on dual energy x-ray absorptiometry is usually reported as indicating that the patient has "osteoporosis" according to the World Health Organization classification, and, in postmenopausal women, it is often assumed that this is due to estrogen deficiency.
+5 more sources
Baillière's Clinical Endocrinology and Metabolism, 1997
Osteomalacia is a generalized bone disorder characterized by impairment of mineralization, leading to accumulation of unmineralized matrix or osteoid in the skeleton. The classical clinical features of osteomalacia include musculoskeletal pain, skeletal deformity, muscle weakness and symptomatic hypocalcaemia.
R M, Francis, P L, Selby
openaire +2 more sources
Osteomalacia is a generalized bone disorder characterized by impairment of mineralization, leading to accumulation of unmineralized matrix or osteoid in the skeleton. The classical clinical features of osteomalacia include musculoskeletal pain, skeletal deformity, muscle weakness and symptomatic hypocalcaemia.
R M, Francis, P L, Selby
openaire +2 more sources
Seminars in Musculoskeletal Radiology, 2002
Oncogenic osteomalacia is a rare paraneoplastic syndrome caused by bone and soft tissue tumors. The characteristic clinical, metabolic, and imaging findings are reviewed, as is the radiologist's role in evaluation and diagnosis. New insight into the pathophysiology of oncogenic osteomalacia is also presented.
Kelli Andresen, Edmister +1 more
openaire +2 more sources
Oncogenic osteomalacia is a rare paraneoplastic syndrome caused by bone and soft tissue tumors. The characteristic clinical, metabolic, and imaging findings are reviewed, as is the radiologist's role in evaluation and diagnosis. New insight into the pathophysiology of oncogenic osteomalacia is also presented.
Kelli Andresen, Edmister +1 more
openaire +2 more sources
Burosumab in Tumor-Induced Osteomalacia: A Case Report.
Joint, bone, spine : revue du rhumatisme, 2019Tumor-induced osteomalacia is a rare cause of acquired hypophosphatemia due to the paraneoplastic overproduction of fibroblast growth factor-23. Unlike many causes of osteomalacia, tumor-induced osteomalacia is curable by resection of the offending tumor.
Alvin Lee Day +3 more
semanticscholar +1 more source
Human Pathology, 2018
Phosphaturic mesenchymal tumor (PMT) is a rare, histologically distinctive neoplasm that classically presents with phosphaturia and tumor-induced osteomalacia (TIO; ie, oncogenic osteomalacia).
K. Sent-Doux +4 more
semanticscholar +1 more source
Phosphaturic mesenchymal tumor (PMT) is a rare, histologically distinctive neoplasm that classically presents with phosphaturia and tumor-induced osteomalacia (TIO; ie, oncogenic osteomalacia).
K. Sent-Doux +4 more
semanticscholar +1 more source
Four possible cases of osteomalacia: The value of a multidisciplinary diagnostic approach.
International Journal of Paleopathology, 2018Rickets and residual rickets are often encountered in Dutch archeological skeletal samples. However, no archeological Dutch paleopathological case of adult osteomalacia has been described in literature to date.
A. E. van der Merwe +5 more
semanticscholar +1 more source
FGF23 and Hypophosphatemic Rickets/Osteomalacia
Current Osteoporosis Reports, 2021Y. Takashi, Daiji Kawanami, S. Fukumoto
semanticscholar +1 more source